Showing results (221-230 of 364) with videos related to

Sort By:
Pageof 37
Transplantation|November 7, 2013
Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donorsKrista L Lentine, Mark A Schnitzler, Huiling Xiao, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 28, 2016
The Changing Financial Landscape of Renal Transplant Practice: A National Cohort AnalysisD A Axelrod, M A Schnitzler, H Xiao, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 28, 2010
The interplay of socioeconomic status, distance to center, and interdonor service area travel on kidney transplant access and outcomesDavid A Axelrod, Nino Dzebisashvili, Mark A Schnitzler, et al.
Transplantation Proceedings|November 25, 2010
The clinical importance of flow cytometry crossmatch in the context of CDC crossmatch resultsR J Graff, P M Buchanan, N Dzebisashvili, et al.
American Journal of Nephrology|September 9, 2014
Understanding antihypertensive medication use after living kidney donation through linked national registry and pharmacy claims dataKrista L Lentine, Mark A Schnitzler, Amit X Garg, et al.
Transplantation|April 24, 2015
Race, Relationship and Renal Diagnoses After Living Kidney DonationKrista L Lentine, Mark A Schnitzler, Amit X Garg, et al.
Transplantation|July 17, 2004
Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantationKaren L Hardinger, Mark A Schnitzler, Brent Miller, et al.
Pharmacoeconomics|February 6, 1997
A pharmacoeconomic comparison of antithymocyte globulin and muromonab CD3 induction therapy in renal transplant recipientsD C Brennan, M A Schnitzler, J D Baty, et al.
Transplantation|February 6, 2019
Racial/Ethnic Disparities in Access and Outcomes of Simultaneous Liver-Kidney Transplant Among Liver Transplant Candidates With Renal Dysfunction in the United StatesSu-Hsin Chang, Mei Wang, Xiaoyan Liu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 24, 2002
Prospective, pilot, open-label, short-term study of conversion to leflunomide reverses chronic renal allograft dysfunctionKaren L Hardinger, Candace D Wang, Mark A Schnitzler, et al.
Pageof 37